About Endo International
Endo International is a company based in Malvern (United States) founded in 1997.. The company has 1,431 employees as of September 30, 2024. Endo International has completed 14 acquisitions, including American Medical Systems, Auxilium Pharmaceuticals and BML Pharma. Endo International offers products and services including Sterile Injectables and Generics. Endo International operates in a competitive market with competitors including Merck, Roivant Sciences, Gilead, Lilly and Vertex Pharmaceuticals, among others.
- Headquarter Malvern, United States
- Employees 1431 as on 30 Sep, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Endo, Inc.
-
Annual Revenue
$2.01 B-13as on Dec 31, 2023
-
Net Profit
$-2.45 B16as on Dec 31, 2023
-
EBITDA
$-960.07 M72as on Dec 31, 2017
-
Latest Funding Round
$170.57 M (USD), Post-IPO
Mar 21, 2024
-
Investors
HHS
& 1 more
-
Employee Count
1431
as on Sep 30, 2024
-
Investments & Acquisitions
American Medical Systems
& 13 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Endo International
Endo International offers a comprehensive portfolio of products and services, including Sterile Injectables and Generics. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Products for hospital use in reducing complexity and enhancing patient care
High-quality generic medicines for retail and pharmacy distribution
Unlock access to complete
Unlock access to complete
Sales and Marketing
45 people
Software Development Team
40 people
Leadership Team
26 people
Product Management Team
15 people
Operations Team
13 people
Human Resources and Administration
9 people
Legal and Compliance
7 people
Senior Team
4 people
Unlock access to complete
Funding Insights of Endo International
- Total Funding Total Funding
- Total Rounds 3
- Last Round Post-IPO — $170.6M
- First Round First Round
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2024 | Amount | Post-IPO - Endo International | Valuation |
investors |
|
| Feb, 2011 | Amount | Grant - Endo International | Valuation |
investors |
|
| Jun, 1997 | Amount | Unspecified - Endo International | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Endo International
Endo International has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS and Kelso & Company. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are directed toward multiple sectors.
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Endo International
Endo International has strategically engaged in corporate development activities, having acquired 14 companies. Notable acquisitions include American Medical Systems, Auxilium Pharmaceuticals and BML Pharma. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Energy and telecommunications cable systems are manufactured and distributed internationally.
|
2015 | ||||
|
Comprehensive EMR software for urologists is developed and offered.
|
2005 | ||||
|
Generic drugs are manufactured and distributed by DAVA Pharmaceuticals.
|
2004 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Endo International
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Endo International Comparisons
Competitors of Endo International
Endo International operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, Roivant Sciences, Gilead, Lilly and Vertex Pharmaceuticals, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical products are manufactured and marketed worldwide.
|
|
| domain | founded_year | HQ Location |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
|
|
| domain | founded_year | HQ Location |
Traditional pharmaceutical medicines are developed for multiple health fields.
|
|
| domain | founded_year | HQ Location |
Developer of drugs for the treatment of multiple disorders
|
|
| domain | founded_year | HQ Location |
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Endo International
Frequently Asked Questions about Endo International
When was Endo International founded?
Endo International was founded in 1997.
Where is Endo International located?
Endo International is headquartered in Malvern, United States. It is registered at Malvern, Pennsylvania, United States.
How many employees does Endo International have?
As of Sep 30, 2024, the latest employee count at Endo International is 1,431.
What is the annual revenue of Endo International?
Annual revenue of Endo International is $2.01B as on Dec 31, 2023.
What does Endo International do?
Endo International, backed by 171246909.0 from HHS, Kelso Company, focuses on providing healthcare solutions, diversified pharmaceuticals, and drugs. Global pharmaceutical company manufacturing branded, generic formulations, and OTC medicines. Driving innovation, growth, and excellence in its industry sectors. It continues to evolve, meeting industry challenges with strategic approaches.
Who are the top competitors of Endo International?
Endo International's top competitors include Merck, Roivant Sciences and AbbVie.
What products or services does Endo International offer?
Endo International offers Sterile Injectables and Generics.
How many acquisitions has Endo International made?
Endo International has made 14 acquisitions, including American Medical Systems, Auxilium Pharmaceuticals, and BML Pharma.
Who are Endo International's investors?
Endo International has 2 investors. Key investors include HHS, and Kelso & Company.